Jacob Lange Moresco
Investment Director @ Sunstone Life Science Ventures
Copenhagen, Denmark
Jacob Lange Moresco is a Series A investor at Sunstone Life Science Ventures in Copenhagen focused on Biotechnology and Medical. Jacob Moresco joined the Life Science team as an associate in 2010. Jacob focuses on deal flow management and data analysis. He is also closely involved in due diligence investigations and the execution of internal investment documents.Previously, Jacob held a Post Doc position at the department for micro- and nanotechnology at the TechnicalUniversity of Denmark (DTU). His industry experience includes drug discovery and software tool development at TopoTarget and Chr. Hansen, respectively. Jacob holds a Master’s degree in Biotech Engineering and a PhD in the fields of microfabrication, microfluidics, and diagnostics – both from DTU. Out-of-office hours are divided between time with the family and outdoor activities such as fly fishing, badminton, cycling, running, and free diving spear hunting.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Jacob Lange Moresco invests in
Stages Jacob Lange Moresco invests in
Countries Jacob Lange Moresco invests in
Investment Focus
Industry
- Biotechnology 2 (100%)
- Medical 1 (50%)
- Health Care 1 (50%)
- Therapeutics 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Series A 1 (50%)
- Series B 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Kynexis
|
Kynexis is advancing the first potential precision medicine for the treatment of cognitive impairment associated with schizophrenia (CIAS). | $61M / Series A / Nov 07, 2023 | |
Step Pharma
|
Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe. | $41.3M / Series B / Mar 24, 2021 |
Co-Investors
About Sunstone Life Science Ventures
Sunstone Life Science Ventures is a European, early-stage VC investing in novel pharmaceutical ingredients for human therapeutic use
Sunstone Life Science Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Claus A. Andersson
General Partner
|
|||
|
Jacob Lange Moresco
Investment Director
|
|||
Line Jacobsen
Management Assistant
|
|||
Peter Benson
Chairman and Managing Partner
|
|||
Sten Verland
Co-Founder & General Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jacob Lange Moresco invest in?
Jacob Lange Moresco invests primarily in Biotechnology, Medical and Health Care startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Jacob Lange Moresco last invest?
The most recent investment recorded for Jacob Lange Moresco closed in Nov 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
